Stroke

Results of a recent analysis that found ablation was associated with lower risk of dementia compared to medical therapy alone suggest rhythm control could help preserve overall health.

The Thermocool Smarttouch SF Catheter received approval for use with the CARTO® 3 System, according to a statement from the Johnson & Johnson Medical Companies.

Could an alarm clock in the room where stroke care is performed contribute to more streamlined care?

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

A study from ESC Congress 2020 details the effects of initiating rhythm control within the first year of an atrial fibrillation diagnosis.

Lead investigator of IMPACT-AFib discusses the results of the study and how they inform clinicians on strategies to improve oral anticoagulant use.

Results of HOME-PE suggest an approach using HESTIA was noninferior to sPESI for patients with acute pulmonary embolism.

A pair of studies provides an overview of declines in use of cardiology services and patients presenting with adverse cardiovascular events during the pandemic.

Quitting smoking at the time of an Afib diagnosis could reduce risk of incident stroke event by 28%, according to a new analysis from ESC 2020.

Across racial and gender groups, CT scans that measure coronary artery calcium can more accurately predict the 10-year risk for heart attack.

Our latest case report from Dr. Brady Pregerson features a 72 y/o male with a history of hypertension and TIA. Check out the EKG and see if you can determine the diagnosis.

A meta-analysis of 4 randomized trials is shedding light on the efficacy and safety of direct oral anticoagulant use for reducing recurrent VTE in patients with cancer.

Director of Yale's Pulmonary Vascular Disease Program offers insight from a recent study he led attempting to determine the root cause of blood clots in COVID-19 patients.

A study from BCVS 2020 is shedding light on the potential cardiovascular benefits of receiving a seasonal influenza vaccination in patients at high risk for the flu.

Deepak Bhatt, MD, MPH, discusses the latest REDUCE-IT data presented at ASPC 2020 in an exclusive interview with Practical Cardiology.

S. Claiborne Johnston discusses the results of the phase 3 THALES trial examining use of ticagrelor dual antiplatelet therapy for reducing subsequent stroke in patients with AIS or TIA.

New research suggests IVC filter placement could attenuate the risk of pulmonary embolism in patients with cancer-related DVT.

A study from Vanderbilt University Medical Center details the apparent risks associated with bleeding and venous thromboembolism following noncardiac surgery.

Results of the phase 3 THALES trial detail the effect of ticagrelor DAPT for reducing the risk of stroke and death in patients with acute ischemic stroke or transient ischemic attack.

An analysis of the REGARDS study is shedding new light on the impact multiple social determinants of health can have on a patient's stroke risk.

Rates of recurrent stroke have been on the decline in recent years—reaching a rate similar to that of non-Hispanic whites by 2013.

Two major organizations have released a new statement outlining topics of research related to VTE in need of further research going forward.

An associate professor of medicine at Yale School of Medicine discusses the results of a study aimed at assessing the potential pathophysiology of COVID-19-associated blood clots.

New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.

The AAN has released an update to their 2016 practice advisory—changing their stance on PFO closure to reduce risk of second stroke.